Cargando…

Preventing readmissions of COPD patients: more prospective studies are needed

Identifying risk factors for readmission will help in the management of severe COPD patients https://bit.ly/2zFVUsj

Detalles Bibliográficos
Autores principales:	Nuñez, Alexa, Miravitlles, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489122/ https://www.ncbi.nlm.nih.gov/pubmed/32499307 http://dx.doi.org/10.1183/16000617.0097-2020

Ejemplares similares

Long-term antibiotics in COPD: more benefit than harm?
por: Miravitlles, Marc
Publicado: (2013)

COPD heterogeneity: implications for management
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Bronchiectasis in COPD patients: more than a comorbidity?
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2017)

The overlap phenotype: the (missing) link between asthma and COPD
por: Piras, Barbara, et al.
Publicado: (2012)

Predicting and preventing hospital readmission for exacerbations of COPD
por: Kong, Chia Wei, et al.
Publicado: (2020)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)

Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
por: Núñez, Alexa, et al.
Publicado: (2018)

Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
por: Lau, Christine SM, et al.
Publicado: (2017)

Can Macrolide Antibiotics Prevent Hospital Readmissions?
por: Wedzicha, Jadwiga A., et al.
Publicado: (2019)

Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
por: Miravitlles, Marc, et al.
Publicado: (2021)

Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
por: Li, Qing, et al.
Publicado: (2019)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

COPD: more treatment will translate to better breathing. Will it?
por: Teixeira, Paulo José Zimermann, et al.
Publicado: (2019)

Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT(®) studies
por: Miravitlles, Marc, et al.
Publicado: (2009)

Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study
por: Alqahtani, Jaber S, et al.
Publicado: (2021)

No More Need Apply
Publicado: (1894)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study
por: Calle Rubio, Myriam, et al.
Publicado: (2017)

Understanding the impact of symptoms on the burden of COPD
por: Miravitlles, Marc, et al.
Publicado: (2017)

Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis
por: Martinez-García, Miguel Angel, et al.
Publicado: (2022)

Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2015)

Hospital readmissions for COPD: a retrospective longitudinal study
por: Harries, Timothy H., et al.
Publicado: (2017)

Need of More Medical Officers
Publicado: (1918)

The need for a national perspective to improve COPD management
por: Marco, Fabiano Di, et al.
Publicado: (2019)

Women and COPD: do we need more evidence?
por: Gut-Gobert, Christophe, et al.
Publicado: (2019)

Chronic bronchial infection in COPD. Is there an infective phenotype?
por: Matkovic, Zinka, et al.
Publicado: (2013)

Caregivers’ burden in patients with COPD
por: Miravitlles, Marc, et al.
Publicado: (2015)

Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients?
por: Cen, Lai-Jian, et al.
Publicado: (2021)

Have rates of readmission for COPD been overestimated?
por: White, Patrick T, et al.
Publicado: (2016)

Update on Asthma–COPD Overlap (ACO): A Narrative Review
por: Mekov, Evgeni, et al.
Publicado: (2021)

Orthogeriatrics: much more action is needed
por: Ranhoff, Anette Hylen
Publicado: (2020)

Construction industry: More needs to be done
por: Kulkarni, G. K.
Publicado: (2007)

Trauma outcome research – More is needed
por: Wisborg, T., et al.
Publicado: (2017)

Noise pollution: more attention is needed
por: The Lancet Regional Health – Europe
Publicado: (2023)

We Need More COVID Therapies
por: Somberg, John
Publicado: (2023)

More Data on Risks and Outcomes of COVID-19 in Asthma, COPD, and Bronchiectasis
por: Chung, Kian Fan
Publicado: (2021)

Pseudomonas aeruginosa infection increases the readmission rate of COPD patients
por: Choi, Juwhan, et al.
Publicado: (2018)

Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tk65qqp7tnmban9dia63tkajv3